Grandview Asset Management LLC Seagen Inc. Transaction History

Grandview Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$135.08 - $161.1 $243,144 - $289,980	-1,800 Closed	0 $0
Q1 2021 May 06, 2021	BUY	$137.51 - $190.8 $240,917 - $334,281	1,752 Added 3650.0%	1,800 $250,000
Q1 2021 May 06, 2021	SELL	$137.51 - $190.8 $295,921 - $410,601	-2,152 Reduced 97.82%	48 $11,000
Q4 2020 Jan 21, 2021	BUY	$164.63 - $211.93 $362,186 - $466,246	2,200 New	2,200 $385,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Grandview Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Grandview Asset Management LLC with notifications on news.